Reminder: Virtual Town Hall on the Production and Use of 3D Printed Swabs with Coronavirus Disease 2019 (COVID-19) Diagnostic Tests

Today - May 15th, from 1:00-2:00 p.m. ET, the U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for researchers, clinical laboratories, and commercial manufacturers to discuss the production and use of 3D printed swabs during the COVID-19 public health emergency. This is a collaboration between the FDA, the Department of Veterans Affairs’ (VA) Innovation Ecosystem, and the National Institutes of Health’s (NIH) 3D Print Exchange.

During this Town Hall, representatives from each of these Agencies will discuss their proposed regulatory science research aims regarding the design, manufacturing, and use of 3D printed swabs during the COVID-19 public health emergency. They will also provide an overview of their partnership, including best scientific practices and processes for the manufacture and validation of these 3D printed products, and will answer technical questions about the proposed scientific research regarding the development and validation of swabs manufactured through unconventional means for use with COVID-19 testing.

To ensure you can participate, please dial in 15 minutes prior to the start of the Town Hall.

View the Town Hall Details